Boehringer Ingelheim Vetmedica has re-launched its Vetmedin website: www.vetmedin.co.uk.

Boehringer says the new site has been designed as a resource for veterinary professionals to help educate clients with dogs suffering from congestive heart failure…

Boehringer Ingelheim Vetmedica has increased its range of marketing and educational materials about heart disease and the use of Vetmedin.

The materials include canine heart disease awareness posters for either the waiting room or consult room which feature…

Boehringer Ingelheim Vetmedica has launched Benefortin (benazepril hydrochloride), an ACE inhibitor licensed for the treatment of congestive heart failure (CHF) in dogs. It is also licensed for the treatment of chronic renal insufficiency (CRI) in cats.

According to the company, the new injectable form of Vetmedin provides rapid acting treatment for canine congestive heart failure originating from valvular…